CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-21 | Rubin Marc Director | Grant or award · Non Qualified Stock Option | +4,250 | $11.62 | $49K | 4,250 |
| 2024-05-21 | Borgman Anne Elizabeth Director | Grant or award · Non Qualified Stock Option | +4,250 | $11.62 | $49K | 4,250 |
| 2024-05-21 | Hohneker John Director | Grant or award · Non Qualified Stock Option | +4,250 | $11.62 | $49K | 4,250 |
| 2024-05-21 | GREENACRE MARTYN D Director | Grant or award · Non Qualified Stock Option | +4,250 | $11.62 | $49K | 4,250 |
| 2023-05-01 | Zung Jonathan B. CDO | Grant or award · Employee stock option (right to buy) | +500,000 | $0.83 | $415K | 500,000 |
| 2023-01-23 | KAITIN KENNETH I Director | Grant or award · Non Qualified Stock Option | +85,000 | 85,000 | ||
| 2023-01-23 | Hohneker John Director | Grant or award · Non Qualified Stock Option | +85,000 | 85,000 | ||
| 2023-01-23 | Rubin Marc Director | Grant or award · Non Qualified Stock Option | +85,000 | 85,000 | ||
| 2023-01-23 | GREENACRE MARTYN D Director | Grant or award · Non Qualified Stock Option | +85,000 | 85,000 | ||
| 2023-01-23 | Borgman Anne Elizabeth Director | Grant or award · Non Qualified Stock Option | +85,000 | 85,000 | ||
| 2023-01-20 | Duvall Diantha CFO | Grant or award · Employee stock option (right to buy) | +500,000 | 500,000 | ||
| 2023-01-20 | Martell Robert Head of Research & Development | Grant or award · Employee stock option (right to buy) | +350,000 | 350,000 | ||
| 2023-01-20 | Dentzer James E President & CEO | Grant or award · Employee stock option (right to buy) | +1,000,000 | 1,000,000 | ||
| 2022-10-12 | Borgman Anne Elizabeth Director | Grant or award · Non Qualified Stock Option | +25,000 | 25,000 | ||
| 2022-01-31 | Rubin Marc Director | Grant or award · Non Qualified Stock Option | +85,000 | 85,000 | ||
| 2022-01-31 | Kunkel Lori Anne Director | Grant or award · Non Qualified Stock Option | +85,000 | 85,000 | ||
| 2022-01-31 | KAITIN KENNETH I Director | Grant or award · Non Qualified Stock Option | +85,000 | 85,000 | ||
| 2022-01-31 | Hohneker John Director | Grant or award · Non Qualified Stock Option | +85,000 | 85,000 | ||
| 2022-01-31 | GREENACRE MARTYN D Director | Grant or award · Non Qualified Stock Option | +85,000 | 85,000 | ||
| 2022-01-31 | Dentzer James E President & CEO | Sale | −3,094 | $3.07 | $9K | 64,877 |
Page 4 of 17 · 326 trades